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Abstract
Background—Formalin-fixed paraffin-embedded (FFPE) samples can be DNA-extracted and 
used for human papillomavirus (HPV) genotyping. The xylene-based gold standard for extracting 
FFPE samples is laborious, suboptimal and involves health hazards for the personnel involved.
Objectives—To compare extraction with the standard xylene method to a xylene-free method 
used in an HPV LabNet Global Reference Laboratory at the Centers for Disease Control (CDC); 
based on a commercial method with an extra heating step.
Study design—Fifty FFPE samples were randomly selected from a national audit of all cervical 
cancer cases diagnosed in Sweden during 10 years. For each case-block, a blank-block was 
sectioned, as a control for contamination. For xylene extraction, the standard WHO Laboratory 
Manual protocol was used. For the CDC method, the manufacturers’ protocol was followed except 
for an extra heating step, 120°C for 20 minutes. Samples were extracted and tested in parallel with 
β-globin real-time PCR, HPV16 real-time PCR and HPV typing using modified general primers 
(MGP)-PCR and Luminex assays.
Results—For a valid result the blank-block had to be betaglobin-negative in all tests and the 
case-block positive for beta-globin. Overall, detection was improved with the heating method and 
the amount of HPV-positive samples increased from 70% to 86% (p=0.039). For all samples where 
HPV type concordance could be evaluated, there was 100% type concordance.
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Conclusions—A xylene-free and robust extraction method for HPV-DNA typing in FFPE 
material is currently in great demand. Our proposed standardized protocol appears to be generally 
useful.
Keywords
Human papillomavirus (HPV); Formalin-Fixed Paraffin-Embedded (FFPE); DNA-extraction; 
Genotyping; xylene
Background
Human Papillomavirus (HPV) infections are known to be a major cause of cervical cancer 
(1). More than 200 types of HPV have been fully characterized (2). HPV types are divided 
in high-risk and low-risk viruses, where the high-risk types, notably HPV16 and HPV18, 
predominate in HPV-related cancers (1). In light of current developments in HPV-based 
screening and HPV vaccination, it is important to develop a robust method for HPV 
genotyping and detection in cervical tissue, to be able to analyze the HPV-type-specific 
disease burden and to monitor the effectiveness of HPV prevention programs (3).
Formalin-fixed paraffin-embedding (FFPE) of tissues is suitable for long-term storage of 
cancer tissue samples and has been globally used in pathology for more than a century. 
FFPE cancer tissue has often been used for analyzing presence and type of HPV in cancers, 
for example in order to determine the HPV type-specific burden of disease in various regions 
of the world and over time (4). However, the analysis of FFPE specimens includes several 
potential problems including DNA cross-linking, DNA fragmentation and the presence of 
PCR inhibitors (4, 5). The goldstandard method for extracting these samples before HPV 
testing is xylene-based extraction (6). However, xylene-based extraction is laborious, known 
to result in suboptimal sensitivity and also involves health hazards for the personnel 
involved. Recently, a method combining heat treatment and a commercially available DNA 
extraction kit was evaluated compared to xylene-based extraction, showing higher DNA 
yield and increased sensitivity for HPV testing (5) We wished to further evaluate and 
investigate the robustness of this method.
Objectives
The aim of this study was to evaluate a xylene-free method for the extraction of HPV-DNA 
in FFPE samples. If found robust, this method could become a new standard method for 
FFPE extraction before HPV genotyping. We thus compared the xylene-based gold standard 
method to a commercial column-based extraction with an extra heating step (5).
Study design
FFPE samples
Fifty FFPE-samples from patients with cervical cancer were randomly selected from a 
national case-control audit encompassing all invasive cervical and unspecified uterine 
cancers diagnosed from 2002 until 2011 in Sweden, the Advancing Cervical Cancer 
Eradication Strategies, ACCES, study. The diagnostic slides and the formalin-fixed paraffin-
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embedded (FFPE) tissue blocks were collected from different pathology biobanks 
throughout Sweden. Here, we selected fifty samples from one biobank, Gävleborg. The 
diagnostic slides were re-reviewed by an experienced histopathologist and only tissues 
where presence of cervical cancer could be verified were retained in this study.
Sectioning
All FFPE blocks were sent to a commercial, accredited laboratory (HistoCenter, Inc., 
Gothenburg, Sweden) for sectioning. In-between each case-block, a paraffin blank-block 
was sectioned, as a control for contamination. Every case required new gloves and a new 
knife. The blank-block was sectioned first. Four 5 μm sections were transferred to a 1,5 mL 
screw-cap Eppendorf tube using a new, clean, toothpick. The case-block was mounted on the 
microtome and sectioned with the same knife. Each case was sectioned in six 5 μm sections. 
The first and last section were set aside for histological review and two times two 5 μm 
sections were put in two tubes, one tube per extraction method, for HPV testing. The slides 
for histology were stained with hematoxylin-eosin. The tubes were marked with the blocks 
specific lab number, B (blank-block) and C (case-block). The slides were marked in the 
same way, with the specific lab number followed by letters F (first) and L (last). After each 
case the knife was removed and the microtome was cleaned with DNAZap (Applied 
Biosystems). Specimen size was determined in millimeters, using a ruler, with size in square 
millimeters being the product of length and width. Although all cases included in the study 
had been verified to contain tumor tissue, sections from HPV-negative tumors were re-
reviewed a second time and still found to contain tumor tissue.
DNA extraction
DNA was extracted from the sectioned blocks using two different extraction methods: 1) A 
method developed at CDC using the Qiagen blood and tissue kit with an extra heating step 
(5) and 2) the xylene-based gold standard method (6). The extra heating step has been 
reported to result in an 8.2 fold increase in PCR-amplifiable cellular DNA and a decrease in 
inadequate results (5.3%, down from 19.3%) (5).
One tube from each FFPE sample was extracted with xylene. The paraffin was removed by 
incubation with 1 mL xylene in 50°C for 30 min followed by vortexing and centrifugation 
3000 × g, 10 min, the supernatant was removed with a sterile transfer pipette. This step was 
repeated once. After removing the xylene the samples was washed twice with pure ethanol 
and air dried. The air dried pellet was incubated with 100 μL Digestion buffer (50 mM Tris 
HCl,1 mM EDTA, pH 8,5) with Proteinase K (50 mg/mL) in 37°C for about 24 h. After 
incubation the samples were boiled in 100°C for 10 min to inactivate Proteinase K.
The other tube from each FFPE sample was extracted with the Qiagen/heating method. 180 
μL ATL buffer was added to the tube and high-heat treated in 120°C for 20 min to melt the 
paraffin. Within the 5 first minutes the tubes were mixed by tapping the tube to make sure 
that all of the paraffin was under the surface. After 20 minutes the samples were incubated at 
room temperature for 3 minutes, followed by a quick centrifugation. 20 μL proteinase K was 
added, briefly vortex and incubated in 65°C for 16 hours (the manufacturer’s protocol 
describes 56°C, but a previous study found 65°C to be better (5)). The tubes where quickly 
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centrifuged. A solution of 200 μL buffer AL and 200 μL ethanol, per sample, was prepared. 
After adding 400 μL of the prepared solution immediate vortex was needed. The mixture 
was added to a DNeasy Mini spin column and centrifuged 1 min at 8000 rpm. The following 
steps were performed according to the manufacturer’s protocol except for the volume in the 
elution step that was changed to 100 μL AE buffer. In total 200 extractions were performed.
Quantitative real-time PCR for beta-globin and HPV16
All samples were tested for both beta-globin and HPV16 in real-time PCR, as previously 
described (7, 8). Samples from the two extraction methods were tested in parallel in both 
beta-globin and HPV16, undiluted and diluted 1/10 in water.
Briefly, one μL extracted sample was used in the PCR of a total volume of 25 μL. A standard 
program was used, 50°C, 2.0 min, 95°C, 10.0 min; 95°C 15.0 sec, 60°C 1.0 min for 40 
cycles. The following primers and probe were used for HPV16, HPV16 E7 M forward 
5′AGCTCAGAGGAGGAGGATGAA 3′, HPV16 E7 M reverse 5′ 
GGTTACAATATTGTAATGGGCTC 3′ and HPV16 E7 M probe 5′-FAM-
CCAGCTGGACAAGCAGAACCGG-TAMRA-3′.
All samples were analyzed in parallel for quantitative HPV16 real-time PCR, quantitative 
beta-globin real-time PCR and HPV-genotyping. Samples from each individual case-block, 
extracted with the two different extraction methods, were analyzed in parallel in the same 
run in all assays with the same standard curve and positive controls. One μL extracted 
sample was used in all the assays to avoid PCR inhibitors.
For a valid result, the blank-block had to be negative in all three tests and the case-block 
positive for beta-globin, where a measurement of one copy was considered positive. FFPE 
samples are known to contain PCR inhibitors and to avoid this, all 50 samples were tested 
first undiluted and then diluted 1 to 10.
HPV genotyping
HPV detection and genotyping of HPV was done using modified general primers, MGP-
PCR and Luminex as previously described (9). Briefly, one μL was used as input in the 
MGP-PCR in a total volume of 25 μL. The probes used in the multiplex Luminex were, 
HPV6, 11, 16, 18, 18.6650 G variant, 26, 30, 31, 33.2, 35, 35.6624:A variant, 39, 40, 42, 43, 
45, 51, 52, 53, 54, 56, 58.1, 59, 61, 66, 67, 68 prototype (discovered by Gerard Orth, also 
called HPV68a), 68ME.1 (also called HPV68b), 69, 70, 73, 74:911664, 81, 82, 83, 86, 87, 
89, 90, 91, universal1 and universal2 (for probes, see Table 1). Samples positive for probe 
universal1 and/or universal2 were planned to be sequenced to obtain the correct HPV-type.
Statistics
Descriptive data on number and proportion of betaglobin and HPV-positive samples for each 
extraction method were obtained. McNemar’s test was used for paired categorical data, and 
paired t-tests were used for paired measurements of continuous data. Mann-Whitney-
Wilcoxon test was used for the comparison of tumor size and amplifiability..
All tests were two-tailed and a P-value of <0.05 was considered statistically significant.
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Results
One case-block out of 50 extracted with the Qiagen/heating was negative for undiluted beta-
globin compared to 9/50 case-blocks extracted with the xylene method (p=0.008). All the 50 
case-blocks were valid with both extraction methods after 1/10 dilution. Requirement for 
dilution did correlate with size of tumor, with positivity only after dilution being found more 
often in large tissue specimens (p=0.015).
In the HPV16 real-time PCR, one Qiagen/heating-extracted case-block became positive after 
dilution, compared to 4 case-blocks extracted with xylene. Two of the cases extracted with 
the Qiagen/heating method and that were found HPV16-positive had xylene-extracted 
sections that remained negative in HPV16 real-time PCR even after dilution.
HPV16 real-time PCR and genotyping for HPV16 with Luminex had a 96–98% 
concordance for the two extraction methods (data not shown). Mean undiluted copy numbers 
for both beta-globin and HPV16 were about twice as high for Qiagen/heating-extracted case-
blocks compared to xylene extracted case-blocks; HPV16 Qiagen/heating extraction method 
resulted in 104273 copies compared to 50133 copies with xylene extraction. Beta-globin 
Qiagen/heating extraction gave 5525 copies vs 2554 copies with the xylene extraction, 
(p<0.0001 and p=0.036, respectively; Figure 1 and Figure 2). All HPV-negative specimens 
were positive for Beta-globin. HPV negativity tended to associate with large tumors, albeit 
not significantly so (p=0.1).
The most common HPV-type found in the samples extracted by the Qiagen/heating method 
was HPV16 (48%). The second most common type was HPV18 (16%), followed by HPV59 
(6%), (Table 2). 10/50 samples were HPV positive with the Qiagen/heating method but 
negative with xylene extraction; 2/50 xylene-extracted samples were HPV positive but 
negative with Qiagen/heating extraction. 5/50 (10%) of the xylene-extracted case-blocks had 
to be diluted to get a positive HPV result compared to 0/50 of the Qiagen/heating-extracted 
(p=0.06). Overall, detection was improved with the Qiagen/heating method and the amount 
of HPV-positive samples increased from 70% to 86% (35/50 samples extracted with xylene 
versus 43/50 samples extracted with the Qiagen/heating method, p=0.039). Requirement for 
dilution did correlate with size of tumor (p=0.015). HPV negativity tended to associate with 
large tumors, albeit not significantly so (p=0.1).
Discussion
In a systematic comparison of two extraction protocols designed for FFPE tissue; standard 
xylene-based and a method using Qiagen columns augmented with a heat treatment, we find 
that the Qiagen/heating extraction method was superior in all comparisons made, along with 
the added benefit of a less labor-intensive method and fewer health hazards due to the fact 
that no use of xylene is required. The Qiagen kit is faster to work with and requires less 
handling after extraction, making it more time efficient. The xylene method requires more 
work (including dilution). Hazardous waste is produced, which increases the waste handling 
costs. Overall, the cost of the xylene method when considering consumables only was 0,32 
USD and for the new method 3,34 USD. However, when also considering the technician 
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time required (valued at 24 USD/hour), the xylene method cost 1,4 USD/sample and the new 
method 0,9 USD/sample.
It has been reported that the new method can be used in 96 well plates, amenable to 
automation (5). However, we did not use 96 well plates in this paper as minimizing the risk 
for contamination was a prime concern.
The prime focus of this paper was to investigate robustness and transferability using the key 
type of tissue (cervical cancer) of interest for HPV detection. The original method 
description (5) included tissues other than cervical. Automated use of the new method for 
non-cervical tissues has also been reported (10).
Although the method per se has been published before (5), this report provides an 
independent confirmation of the method improvement and shows that the method is robust 
and can readily be transferred to other laboratories in other countries. This robust and 
improved extraction protocol should be of use in several aspects of monitoring of HPV-
based prevention of cervical cancer, for example impact of HPV vaccination.
With the xylene method, we found only 70% HPV-positive specimens, which increased to 
86% with the new method. While it is generally accepted that cervical cancer “should” be 
HPV positive, studies using formalin-fixed paraffin embedded tissues typically report that a 
significant minority of samples are negative (11). Proposed explanations include cross-
linked and degraded DNA, poor preservation, presence of inhibitors, as well 
misclassification of primary site (confusion between endometrial and endocervical origin), 
presence of HPV types not included in the assay, loss or variant changes in the region 
amplified and rare true negative tumors (6, 11). The detection of HPV is increased when 
very short amplicons are used, but even with this additional testing, in large systematic 
studies, not all cervical cancers have detectable HPV (11). FFPE material is becoming 
widely used in molecular studies and xylene-based extraction has since long been the gold 
standard despite its disadvantages. Other extraction methods have been compared to xylene 
but not with as satisfying results as the Qiagen/heating method (4, 12, 13). Ours was a 
stringently designed validation study where, in order to maximize constancy of other study 
variables and generalizability of results, all 50 case-blocks in the extraction method 
comparison were randomly collected from one biobank in the national study audit. All 
blocks were sectioned at the same accredited laboratory. Furthermore, the same experienced 
pathologist re-reviewed all slides to ensure that representative tumor material was present, 
before initializing DNA extraction protocols. Then, all tests were run in parallel in exactly 
the same fashion, using the same standard curves and dilution protocols such that the only 
differing factor was the extraction method used.
The fact that the Qiagen/heating method does not include xylene is an improvement for both 
the personnel and the environment. The purification step in the Qiagen/heating method also 
leads to fewer inhibitors in the extracted DNA, resulting in fewer steps in the HPV 
genotyping analysis. A xylene-free and robust extraction method for HPV-DNA typing in 
FFPE material currently is in great demand. Our proposed standard method appears to be 
generally useful. Of note, the CDC laboratory has transitioned the Qiagen/heating method to 
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an automated extraction platform. The high temperature dewaxing, along with overnight 
lysis, appear to make the biggest difference in extraction efficiency. High temperatures have 
been used to disrupt formalin cross-links, and this may contribute to the improved yield. (14)
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Figure 1. 
Box plot for betaglobin count in log10 (copies/microliter). Inadequate samples/pairs 
removed (n=9).
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Figure 2. 
Box plot for HPV16 copy number in log10(copies/microliter). Inadequate samples/pairs 
removed (n=5).
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Table 1
Probes used for the different HPV genotypes in Luminex assay.
Probes Sequence
HPV 18.6650 G 5′amino-modified C12- TGC GTC TAC ACA GTC TCC T 3′
HPV 26 5′amino-modified C12- GTA CAT TAT CTG CAG CAT C 3′
HPV 30 5′amino-modified C12- TCT GCA ACC ACA CAA ACG TT 3′
HPV 33.2 5′amino-modified C12- ACA AGT AAC TAG TGA CAG TAC 3′
HPV 35.6624A 5′amino-modified C12- CTG CTG TGT CTA CTA GTG A 3′
HPV 40 5′amino-modified C12- AGT CCC CCA CAC CAA CC 3′
HPV 53 5′amino-modified C12- TGT CTA CAT ATA ATT CAA AGC 3′
HPV 54 5′amino-modified C12- CAC GCA GGA TAG CTT TAA T 3′
HPV 58.1 5′amino-modified C12- CTA ATA TGA CAT TAT GCA CTG AA 3′
HPV 61 5′amino-modified C12- CCC TGT ATC TGA ATA TAA AGC 3′
HPV 67 5′amino-modified C12- CTA CAT ACA AAA ATG AAA AC 3′
HPV 68 (Orth) 5′amino-modified C12- GCT GTG TAT GAT TCT AAT AAA T 3′
HPV 68 ME.1 5′amino-modified C12- CCA ATT TTA CTT TGT CTA CTA CTA C
HPV 69 5′amino-modified C12- CAT CTG CCA CTT TTA AAC C 3′
HPV 74 5′amino-modified C12- CAG ACT ACA AAC AAT ACA TG 3′
HPV 81 5′amino-modified C12- GCT ACA TCT GCT GCT GC 3′
HPV 83 5′amino-modified C12- TGC TGC TAC ACA GGC TAA 3′
HPV 86 5′amino-modified C12- ATT AGT GCC GCT ACC CAG AA 3′
HPV 87 5′amino-modified C12- CCA CTG AAT ATG ACC CCA 3′
HPV 89 5′amino-modified C12- AAT ACA GTT CTA CAC GCT 3′
HPV 90 5′amino-modified C12- CAC ATA CAA GGC TTC CAA TT 3′
HPV 91 5′amino-modified C12- TAC CTA CTA CAT ATG ACA AC 3′
Universal 2 5′amino-modified C12-GMC AYR CAG ARG AAT ATG A 3′
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Table 2
Number (n) and proportion of positivity for HPV genotypes (as well as HPV negative samples) in the 50 FFPE 
samples extracted.
Qiagen/heating method (Positives) Xylene method (Positives)
HPV type Number % Number %
6 1 2% 1 2%
16 23 46% 22 44%
18 8 16% 5 10%
33 2 4% 2 4%
35 1 2% 0 0%
39 1 2% 1 2%
45 2 4% 2 4%
52 1 2% 1 2%
56 1 2% 1 2%
59 2 4% 0 0%
Multiple types 1 2% 0 0%
HPV Negative 7 14% 15 30%
Total 50 100% 50 100%
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